Corpus callosotomy
Corpus Callosotomy is a neurosurgical procedure that involves severing the corpus callosum, the largest white matter structure in the brain, which connects the two cerebral hemispheres. This procedure is typically performed to reduce the severity of seizures in patients with severe, intractable (hard-to-treat) epilepsy.
Indications[edit]
Corpus callosotomy is indicated for patients with severe, intractable epilepsy who have not responded to other treatments, such as antiepileptic drugs or other surgical procedures. The procedure is most commonly used in patients with Lennox-Gastaut syndrome, a severe form of epilepsy that begins in childhood and is characterized by multiple types of seizures and intellectual disability.
Procedure[edit]
During a corpus callosotomy, the patient is placed under general anesthesia. A portion of the skull is removed to expose the brain, and the corpus callosum is carefully severed. The goal of the procedure is to prevent seizure activity from spreading from one hemisphere of the brain to the other, thereby reducing the severity and frequency of seizures.
Risks and Complications[edit]
As with any surgical procedure, corpus callosotomy carries risks, including infection, bleeding, and reactions to anesthesia. Specific to this procedure, there is a risk of disconnection syndrome, a condition in which the two hemispheres of the brain have difficulty communicating with each other. This can result in problems with coordination, speech, and memory.
Outcome[edit]
While corpus callosotomy does not cure epilepsy, it can significantly reduce the severity and frequency of seizures in many patients. Some patients may still require antiepileptic drugs after the procedure, but at lower doses.
See Also[edit]
Corpus callosotomy[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
